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Abstract
Background: Cholesterol 7-alpha-hydroxylase (CYP7A1) is the rate limiting enzyme for
converting cholesterol into bile acids. Genetic variations in the CYP7A1 gene have been associated
with metabolic disorders of cholesterol and bile acids, including hypercholesterolemia,
hypertriglyceridemia, arteriosclerosis, and gallstone disease. Current genetic studies are focused
mainly on analysis of a single nucleotide polymorphism (SNP) at A-278C in the promoter region of
the CYP7A1 gene. Here we report a genetic approach for an extensive analysis on linkage
disequilibrium (LD) blocks and haplotype structures of the entire CYP7A1 gene and its surrounding
sequences in Africans, Caucasians, Asians, Mexican-Americans, and African-Americans.
Result: The LD patterns and haplotype blocks of CYP7A1 gene were defined in Africans,
Caucasians, and Asians using genotyping data downloaded from the HapMap database to select a
set of haplotype-tagging SNPs (htSNP). A low cost, microarray-based platform on thin-film
biosensor chips was then developed for high-throughput genotyping to study transferability of the
HapMap htSNPs to Mexican-American and African-American populations. Comparative LD
patterns and haplotype block structure was defined across all test populations.
Conclusion: A constant genetic structure in CYP7A1 gene and its surrounding sequences was
found that may lead to a better design for association studies of genetic variations in CYP7A1 gene
with cholesterol and bile acid metabolism.
Background
Cholesterol 7-alpha-hydroxylase (CYP7A1) catalyzes the
first reaction in the cholesterol catabolic pathway in liver.
This pathway converts cholesterol to bile acids, which is
the primary mechanism for the removal of cholesterol
from the body. The CYP7A1 catalytic reaction is the rate-
limiting step and the major site for regulating homeostasis
of cholesterol and bile acids. The gene encoding CYP7A1
was cloned by using a rat homolog probe [1] and mapped
to chromosome 8q11 [2]. The CYP7A1 gene spans about
10 kb and contains 6 exons, 5 introns, one 5'-UTR, and
one 3'-UTR. In its 5' flanking region, consensus recogni-
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identified [2]. A TATA box and a modified CAAT box were
also identified in the promoter region of the CYP7A1 gene
[3]. Numerous laboratories have illustrated a multiplex
nuclear receptor mediated network that controls CYP7A1
gene expression and maintains cholesterol and bile acid
balance [4]. Within this network, nuclear receptors of far-
nesoid X receptor (FXR), liver X receptor (LXR), retinoid X
receptor (RXR), small heterodimer partner (SHP), and
liver receptor homologue 1 (LRH1) are involved in a pos-
itive-versus-negative regulation. Using a FXR-deficient (-/-
) mouse model, we have demonstrated feedback suppres-
sion on CYP7A1 gene transcription by FXR [5,6].
Genetic variations in the CYP7A1 gene associated to dis-
orders of cholesterol and bile acid metabolism have been
studied extensively in different laboratories. Most studies
have focused on a single nucleotide polymorphism (SNP)
in the promoter region of the CYP7A1 gene. This is an A/
C transversion polymorphism at -278 from the transla-
tion initiation codon, or -204 from the transcriptional
start site. This polymorphism was first reported by Wang
et al. [7] to link to high plasma low-density lipoprotein
cholesterol concentrations. Association of this polymor-
phism to plasma lipid levels, hypertriglyceridemia, hyper-
cholesterolemia, and risk to arteriosclerosis, gallstone
disease, and colorectal cancer has been studied in adults
and children in Caucasian and Asian populations with
conflicting results [8-19]. A CYP7A1 enzyme deficiency
caused by a homozygous 1302–1303 delTT deletion
mutation in CYP7A1 exon 6, leading to a frameshift
(L413fsX414), has been linked to a hypercholesterolae-
mic phenotype [20]. The information has indicated that
genetic variations in the CYP7A1 gene have high impact
on human cholesterol metabolic regulation and human
health; however, these studies have mainly focused on a
single polymorphism or a mutation. Linkage of genes for
a complex disease relies on having a priori knowledge of
linkage disequilibrium (LD) blocks and haplotype struc-
ture to identify polymorphisms that are associated with
the disease. Therefore, it is important to determine
whether there are LD blocks existing in the CYP7A1 gene
in different populations. This information can be used to
identify a set of haplotype-tagging SNP (htSNP) markers
that can be used in an association study.
The LD blocks and haplotype structure of CYP7A1 gene
can be firstly defined in three general human populations
of Africans, Asians, and Caucasians using a public-availa-
ble database generated by the International HapMap
Project [21]. The HapMap LD patterns and haplotype
structure can serve as reference to select htSNPs for an
association study. LD patterns and htSNPs defined by the
HapMap Project are transferable to other populations in
some loci, but may vary significantly in other loci [22]. To
test whether the htSNPs identified in the HapMap popu-
lations are useful for association studies in other popula-
tions, we analyzed LD patterns and haplotype structures
of CYP7A1 gene in both Mexican-American and African-
American populations using the selected HapMap
htSNPs. Mexican-American is the fastest growing popula-
tion in USA, but genetic study on this population is
extremely limited. Mexican-American genetic background
is a mixture of European American (50–60%) (mainly
Spanish), American Indian (30–40%), and African (<5%)
[23]. African-American is the major minority population
in USA and has an admixture genetic background from
African and European Americans [24]. Genotyping of the
selected htSNPs on these two populations can provide
verification of transferability of the HapMap htSNPs
among populations.
Results and discussion
Linkage disequilibrium blocks and haplotype structures of 
CYP7A1 gene in Caucasians, Africans, and Asians
A LD block is found in the HapMap Caucasians (CEU)
spanning a 14-kb region from the proximal promoter
(rs3824260) to the 3'-downstream (rs10504255) of the
CYP7A1 gene (Figure 1. CEU-B1). A similar LD block
from rs3824260 to the 3'-downstream was also reported
in a Swedish population [18]. About 4.4 kb upstream
from rs3824260, there is another LD block (CEU-B2)
crossing a 3-kb region at the distal promoter region.
Recombination between the two blocks is 0.84. Only five
haplotypes with a frequency > 2% exist in CEU-B1 (Figure
2. CEU-B1H1 to CEU-B1H5). CEU-B1H1 and CEU-B1H2
are two common haplotypes, together representing a total
of 68% of the haplotype frequency in CEU-B1. CEU-B1H1
carries common alleles at all markers except rs8192879 in
3'-UTR, whereas CEU-B1H2 is composed of less common
alleles at 5 out of 8 loci. In CEU-B2, there are only two
types of haplotypes (CEU-B2H1 and CEU-B2H2). CEU-
B2H1 carries common alleles at all SNP loci, whereas
CEU-B2H2 has less common alleles. A similar LD pattern
is found in the HapMap African YRI (Figure 1), but the
larger LD block (YRI-B1) is slight shorter (9 kb from
rs8192879 to rs3824260) than CEU-B1. The haplotype
structure is also similar between YRI and CEU, however,
the frequency of each haplotype is different. The most
common haplotype (55%) in YRI-B1, YRI-B1H1, has
identical haplotype structure with CEU-B1H2, whereas
the second common haplotype in YRI-B1, YRI-B1H2
(22.5%), is the same as CEU-B1H1. YRI-B1H1 and
YRIB1H2 together add up to 77.5% of the total haplo-
types in YRI-B1. In YRI-B2, the dominant haplotype YRI-
B2H1 has the same haplotype structure as CEU-B2H2,
whereas less common haplotype YRI-B2H2 is identical to
the common haplotype CEU-B2H1. A similar recombina-
tion (0.81) is also found between YRI-B1 and YRI-B2. In
CHB and JPT, only one LD block is found from the distalPage 2 of 12
(page number not for citation purposes)
BMC Genetics 2006, 7:29 http://www.biomedcentral.com/1471-2156/7/29promoter to a part of the CYP7A1 gene. Although the JPT-
B1 (16 kb, from rs8192879 to rs1023649) is larger than
CHB-B1 (10 kb, from rs1457043 to rs1023650), LD is
weak between rs8192879 in intron 4 and rs1457043 in
intron 2 in JPT. CHB and JPT share almost the same hap-
lotype structure within the block. JPT-B1H1, JPT-B1H2
and JPT-B1H3 are the same as CHB-B1H1, CHB-B1H2
and CHB-B1H3, respectively. Only CHB-B1H4 (6%) is
unique in CHB.
In comparison of LD and haplotype structure among the
HapMap populations, strong LD is found from the distal
promoter region to intron 2 of the CYP7A1 gene across
the HapMap populations. Two common haplotypes with
complete opposite alleles at all loci (common-versus-less
common alleles) within this region count for more than
85% of total haplotype frequencies in all four HapMap
populations. A diverted LD degree exists between intron 2
and the 3'-downstream region from high to low across
CEU, YRI, JPT, and CHB.
Genotyping of htSNPs in Mexican-Americans and African-
Americans
Because of the strong LD in the CYP7A1 genes, some
markers correlate 100% with each other in a population.
Only a subset of representative SNPs is necessary for
defining a haplotype. These SNPs can tag either neighbor-
ing markers or a set of common haplotypes within an LD
block. The htSNPs in CYP7A1 were selected using Tagger,
implemented in the HaploView 3.12, which combines the
simplicity of pairwise methods with the potential effi-
ciency of multimarker approaches [25]. The CYP7A1
htSNPs are different in the various populations (see
upside-down red triangles in Figure 2 for each HapMap
Linkage disequilibrium of the SNP markers in the CYP7A1 gene in the HapMap populations of CEU, CHB, JPT and YRIFigur 1
Linkage disequilibrium of the SNP markers in the CYP7A1 gene in the HapMap populations of CEU, CHB, JPT and YRI. A 
standard color scheme is used to display LD with bright red color for very strong LD (LOD = 2 D' = 1), white color for no LD 
(LOD<2, D'<1), pink red (LOD = 2 D'<1), and blue (LOD<2 D' = 1) for intermediate LD.
CEU YRI
JPT
CYP7A1
CHB
CYP7A1
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but others for only one or two. It has been suggested that
the populations genotyped in the HapMap project may
serve as reference populations for the selection of htSNP
markers in association studies [26].
Nine SNP markers and one short deletion marker were
selected (see detail in Table 3), in which, eight are htSNP
markers defined by the HapMap populations, including
rs3808607, a functional polymorphism at A-278C in the
promoter region. Two functional mutations were also
included. One is a two-base deletion in exon 6 (1302
delTT) causing a frame shift and CYP7A1 enzyme defi-
ciency [20]. The other one is a C/T SNP in exon 3, causing
an amino acid change at Asn233Ser. This is the only non-
synonymous SNP reported in NCBI SNP database in the
CYP7A1 gene.
To perform genotyping of the 10 markers in the Mexican-
American and African-American populations, a high-
throughput and inexpensive SNP genotyping platform
was developed using thin-film biosensor chips. We have
reported a microarray platform for genotyping both SNPs
and microsattelite repeat on thin-film biosensor chips
[27,28]. The thin-film biosensor chip has excellent sensi-
tivity of detection and extremely low non-specific bind-
ing, making it an excellent platform for discrimination of
polymorphisms [29]. A positive reaction (blue color sig-
nal) can be visualized over the unreacted background
(gold color) by an unaided human eye, without any
instrumentation. Once the chips are printed, they are
Haplotype frequencies of the HapMap selected SNPs in the CYP7A1 gene in CEU, YRI, JPT, and CHBFigure 2
Haplotype frequencies of the HapMap selected SNPs in the CYP7A1 gene in CEU, YRI, JPT, and CHB. In each haplotype, blue 
bars represent allele 1, whereas red bars represent allele 2 for correlated SNPs. Black bars indicate that the SNPs are not 
present in this population. Numbers next to each haplotype bar are haplotype frequencies. Up-side-down red triangles indicate 
htSNPs in the populations. In the crossing areas, a value of multiallelic D' is shown to represent the level of recombination 
between the two blocks.
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in a 96-well plate in a laboratory with a standard molecu-
lar genetics setting within a few hours. Cost for reagents
and materials to genotype 10 CYP7A1 htSNPs, including
genomic DNA isolation, PCR reaction, and SNP genotyp-
ing on the thin-film biosensor chips, is ~US$0.20 per SNP
per sample. It is relative less expensive than other high-
throughput genotype platforms, such as TaqMan or Real-
time PCR.
To verify genotyping specificity on the thin-film biosensor
chips, a pool of the synthetic targets for allele 1 or allele 2
was applied to a chip for hybridization and ligation. After
signals were developed, the result images were captured
by a black-white camera on a Nucleosite™ Image Analyzer
(Biostar, Inc., Louisville, Colorado). High specificity was
achieved on these synthetic targets with unambiguous
genotypes (see images in Figure 3B and 3C). A negative
control showed the signals are target dependent (Figure
3D). As a positive control for genotyping, 12 HapMap
DNA samples were purchased from Coriell Cell Reposi-
tories (Camden, NJ), which are one family trio from YRI
(NA18500, NA18501 and NA18502); one family trio
from CEU (NA06985, NA06991, and NA06993); three
independent individuals from CHB (NA18524,
NA18526, and NA18529); and three independent indi-
viduals from JPT (NA18940, NA18942, and NA18943).
Genotypes of the 8 HapMap htSNPs in the 12 HapMap
samples were determined on thin-film biosensor chips. A
100% concordance was obtained between the 96 geno-
types generated by thin-film biosensor chips and the 96
genotypes downloaded from the HapMap database which
are generated by Illumina Bead Assay.
To define the LD pattern and haplotype structures of
CYP7A1 gene in Mexican-American and African-American
populations, DNA samples from 90 healthy individuals
for each population were randomly selected from our
DNA bank. These DNA samples were collected by other
research projects on alcoholism in the Mexican-American
population [30] and pharmacogenomics of CYP enzymes
in both Mexican-Americans and African-Americans
[31,32]. Genotypes of the 10 selected markers on the 90
Mexican-American and 90 African-American subjects
were determined by using the thin-film biosensor chip
platform. Representative images of the different geno-
Genotyping of the 10 markers of CYP7A1 htSNPs and small deletion on thin-film biosensor chipsFigure 3
Genotyping of the 10 markers of CYP7A1 htSNPs and small deletion on thin-film biosensor chips. A. A design for arraying the 
capture probes on a thin-film biosensor chip. A pair of capture probes for each SNP were arrayed in duplicate next to each 
other with allele 1 left and allele 2 right. M indicates a positive control marker with 20 dATP and 3'-biotin. B. SNP discrimina-
tion with a pool of synthetic oligonucleotide targets of allele 1. C. SNP discrimination with a pool of synthetic oligonucleotide 
targets of allele 2. D. Negative control with no targets. E. A representative image showing genotypes of a Mexican-American 
individual with homozygous allele 1 for the most markers, but homozygous allele 2 for rs8192879. F. A representative image 
showing genotypes of a Mexican-American individual with homozygous allele 2 for the most markers, but homozygous allele 1 
for rs18192879, rs11786580, rs8192874, 1302 TT. G. A representative image showing genotypes of a Mexican-American indi-
vidual with heterozygous for the most markers except rs8192874, 1302 TT.
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3F, and 3G. Genotypes of each individual on the 10 mark-
ers were saved in linkage format and uploaded to HaploV-
iew. Observed genotype frequencies, allele frequencies,
expected heterozygosity, and Hardy-Weinberg p-value of
the 10 markers is summarized in Table 5. No significant
HW p-values (<0.0010) were found. No TT deletion muta-
tion at 1302 and C mutation at rs8192874 were detected
in these two population samples. This indicates that these
mutations have very low frequencies in the general popu-
lations. The genotyping data of the 8 htSNPs were
uploaded to HaploView 3.12 to define LD patterns and
haplotypes structures of CYP7A1. In Mexican-Americans,
three LD blocks were identified. In comparison to the
CEU LD blocks, MA-B3 in the distal promoter region has
the same pattern as CEU-B2, but haplotype frequencies
are different. MA-B3H1 has a frequency (78%) higher
than CEU-B2H1 (55%). Unlike one big block in CEU, the
CYP7A1 gene is divided by two LD blocks in the Mexican-
American population. MA-B2 covers from proximal pro-
moter to intron 2, whereas MA-B1 extents from 3'-UTR to
3'-downstream. The recombination frequencies between
the blocks are 80–90%. In African-Americans, two LD
blocks were recognized. AA-B2 has the identical structure
as YRI-B2 and frequencies of the two haplotypes (AA-
B2H1 and AA-B2H1) in the African-American population
are almost the same as YRI-B2H1 and YRI-B2H2. AA-B1 is
shorter than YRI-B1. The HapMap htSNPs are necessary
SNP markers to capture all haplotypes in the MA and AA
populations.
In summary, the human CYP7A1 gene and its surround-
ing sequences have constant genetic structures across all
populations. This genetic structure can be divided into
Table 2: Genotype frequencies of the 14 CYP7A1 SNPs in the four HapMap populations.
# SNP ID Variation Allele 1/2 CEU CHB JPT YRI
FA2 ObH HW-p FA2 ObH HW-p FA2 ObH HW-p FA2 ObH HW-p
1 rs10504255 A/G 0.317 0.456 1.0 0.200 0.356 0.886 0.170 0.250 0.694 0.017 0.022 1.0
2 rs10957057 C/T 0.142 0.222 1.0 0.122 0.244 0.999 0.159 0.318 0.586 0.092 0.178 1.0
3 rs8192879 C/T 0.367 0.467 0.754 0.267 0.444 0.663 0.261 0.386 1.0 0.225 0.333 1.0
4 rs11786580 C/T 0.242 0.367 1.0 0.056 0.111 1.0 0.091 0.182 1.0 0.192 0.311 1.0
5 rs3747809 A/G 0 0 0.011 0.022 1.0 0.058 0.116 1.0 0 0
6 rs1457043 T/C 0.392 0.522 0.754 0.567 0.556 0.616 0.625 0.523 0.718 0.575 0.467 0.911
7 rs2162459 A/G 0.392 0.522 0.754 0.567 0.556 0.616 0.625 0.523 0.718 0.583 0.456 1.0
8 rs3808607 T/G 0.367 0.489 1.0 0.411 0.467 0.989 0.570 0.535 0.836 0.583 0.456 1.0
9 rs3824260 G/A 0.367 0.489 1.0 0.411 0.467 0.989 0.570 0.535 0.836 0.550 0.478 0.784
10 rs7833904 T/A 0.408 0.511 1.0 0.622 0.533 0.612 0.663 0.535 0.382 0.558 0.444 0.313
11 rs3903445 G/T 0.408 0.511 1.0 0.622 0.533 0.612 0.648 0.523 0.580 0.550 0.467 0.44
12 rs1125226 A/C 0.398 0.517 1.0 0.622 0.533 0.612 0.663 0.535 0.382 0.575 0.456 0.343
13 rs1023649 A/G 0.415 0.517 1.0 0.622 0.533 0.612 0.648 0.523 0.580 0.575 0.456 0.343
14 rs1023652 C/G 0.408 0.511 1.0 0.433 0.556 0.616 0.314 0.488 0.665 0.125 0.189 0.073
FA2: frequency of allele 2; ObH: observed frequency of heterozygous genotypes; HW-p: Hardy-Weinberg p value.
Table 1: Chromosomal positions and gene locations of the 14 CYP7A1 SNPs
# SNP ID Chromosome position Location in CYP7A1 gene Variation* Allele 1/2
1 rs10504255 59448422 3'-downstream A/G
2 rs10957057 59450301 3'-downstream C/T
3 rs8192879 59453537 3'-UTR C/T
4 rs11786580 59455901 Intron 4 C/T
5 rs3747809 59456945 Intron 4 T/C
6 rs1457043 59460400 Intron 2 T/C
7 rs2162459 59461003 Intron 1 A/G
8 rs3808607 59462885 5'-upstream T/G
9 rs3824260 59463151 5'-upstream G/A
10 rs7833904 59467623 5'-upstream T/A
11 rs3903445 59468303 5'-upstream G/T
12 rs1125226 59469472 5'-upstream A/C
13 rs1023649 59470379 5'-upstream A/G
14 rs1023652 59470577 5'-upstream C/G
* Variation allele sequences are based on the plus strand sequence.Page 6 of 12
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BMC Genetics 2006, 7:29 http://www.biomedcentral.com/1471-2156/7/29three components: (1) the distal promoter region, about
7-kb upstream from the transcriptional start code, there is
a 3-kb LD block highly conserved across all populations.
Only two haplotypes exist in this region in the most pop-
ulations, except YRI. The most common haplotype in
CEU and Mexican-American becomes the second most
common haplotypes in YRI, African-American, CHB, and
JPT populations. (2) A relative conserved LD block is
present in the proximal part of CYP7A1 gene from the
proximal promoter region (about 500 bp from the tran-
scriptional start code) to intron 2 of CYP7A1. The two
most conserved haplotypes count for up to 80 to 90% of
the haplotype frequencies in all populations in this
region. (3) A much diverted LD pattern is observed in the
lower part of the CYP7A1 gene (from intron 4 to 3'-down-
stream). In CEU and YRI, a complete or partial LD block
is merged to the block in the proximal part of the CYP7A1
gene. In Mexican-Americans, a LD block in this region is
Table 3: Ten selected genetic variations for CYP7A1 genotyping.
SNP Allele 1/2 Position Note
rs10504255 A/G 3'-downstream HapMap htSNP in CEU
rs8192879 C/T 3'-UTR HapMap htSNP in CEU, JPT, and YRI
1302 delTT TT/-- Exon 6 Frameshift, CYP7A1 deficiency, high hepatic cholesterol content
rs11786580 C/T Intron 4 HapMap htSNP in CEU, JPT, and YRI
rs8192874 C/T Exon 3 Non-synonymous SNP, Asn33Ser
rs216245953 A/G Intron 1 HapMap htSNP in JPT
rs3808607 T/G Promoter HapMap htSNP in CEU and JPT
rs7833904 T/A 5-upstream HapMap htSNP in YRI
rs1125226 A/C 5-upstream HapMap htSNP in JPT
rs1023652 C/G 5'-upstream HapMap htSNP in CEU
LD patterns and haplotype structures of the CYP7A1 gene in Mexican-American and African-American populationsFigure 4
LD patterns and haplotype structures of the CYP7A1 gene in Mexican-American and African-American populations.
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T A C
A C G
Allele 1
Allele 2
9
15
21
95
95
91
96
95
89
19
20
95
86
90
75
89
90
80
97
85
85
2
Block1 Block2 Block3
rs
1
0
5
0
4
2
5
5
rs
8
1
9
2
8
7
9
rs
1
1
7
8
6
5
8
0
rs
2
1
6
2
4
5
9
rs
3
8
0
8
6
0
7
rs
7
8
3
3
9
0
4
rs
1
1
2
5
2
2
6
rs
1
0
2
3
6
5
2
CYP7A1
0.550
0.444
0.575
0.412
0.76
A C C A T
G T C G G
T A C
A C G
Allele 1
Allele 2
71
70
56
66
64
75
81
78
0
56
11
97
74
74
19
74
74
22
28
268
Block1 Block2
69
69
81
78
AA-B1H1
AA-B1H2
0.011Page 7 of 12
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BMC Genetics 2006, 7:29 http://www.biomedcentral.com/1471-2156/7/29Table 4: Oligonucleotide sequences of capture probe P1, detection probe P2, synthetic targets, and PCR primers.
SNP Oligonucleotide sequence
rs10504255 P1-A ALD-AAAAAAAAAAAACCTGAGCACTAGCCAGCTGTGTTCTCAATTCTGTGTGTAA
rs10504255 P1-G ALD-AAAAAAAAAAAACCTGAGCACTAGCCAGCTGTGTTCTCAATTCTGTGTGTAG
rs10504255 P2 Phosphate-CTCTTTCCCAATATTTCAAT-biotin
rs10504255 Target for P1-A ATTGAAATATTGGGAAAGAGTTACACACAGAATTGAGAACA
rs10504255 Target for P1-G ATTGAAATATTGGGAAAGAGCTACACACAGAATTGAGAACA
rs10504255 Forward TAAACCTGCCTTGTCACGC
rs10504255 Reverse AGTTGCAAACGCTGGTTG
rs8192879 P1-C ALD-AAAAAAAAAAGAAAAAACAATCTGCCAATTAGAATACATATCTTTTCTTC
rs8192879 P1-T ALD-AAAAAAAAAAGAAAAAACAATCTGCCAATTAGAATACATATCTTTTCTTT
rs8192879 P2 Phosphate-GGAGACGGGATCTCACTAAG-biotin
rs8192879 Target for P1-C CTTAGTGAGATCCCGTCTCCGAAGAAAAGATATGTATTCTA
rs8192879 Target for P1-T CTTAGTGAGATCCCGTCTCCAAAGAAAAGATATGTATTCTA
rs8192879 Forward ACCTGTAGTCTTAGCTACTCG
rs8192879 Reverse CCTTAGGAAAAAACAATCTGCC
rs11786580 P1-C ALD-AAAAAAAAAACATTTACAAGAACCTATTTTTATCCATATACTATCTGATGC
rs11786580 P1-T ALD-AAAAAAAAAACATTTACAAGAACCTATTTTTATCCATATACTATCTGATGT
rs11786580 P2 Phosphate-TGCGTGGCGATCACCGCTGC-biotin
rs11786580 Target for P1-C GCAGCGGTGATCGCCACGCAGCATCAGATAGTATATGGATA
rs11786580 Target for P1-T GCAGCGGTGATCGCCACGCAACATCAGATAGTATATGGATA
rs11786580 Forward TCTAGGTGTTTAATGCAGCTTC
rs11786580 Reverse GTCCCTTTATGCCTTTACCG
rs8192874 P1-C ALD-AAAAAAAAAATTCTCGTGCCTCAAGCTCTCTGCCAGTTTCTCCCGGGCAC
rs8192874 P1-T ALD-AAAAAAAAAATTCTCGTGCCTCAAGCTCTCTGCCAGTTTCTCCCGGGCAT
rs8192874 P2 Phosphate-TGTGCGCAGTCCTGAACATG-biotin
rs8192874 Target for P1-C CATGTTCAGGACTGCGCACAGTGCCCGGGAGAAACTGGCAG
rs8192874 Target for P1-T CATGTTCAGGACTGCGCACAATGCCCGGGAGAAACTGGCAG
rs8192874 Forward TCAGTTCTGAGATGCTTTCCC
rs8192874 Reverse AGTCTTTCCAGCCCTGGTAG
rs2162459 P1-A ALD-AAAAAAAAAATCTCTAGAGGTGGTTCACCCGTTTGCCTGTCAGACACAAA
rs2162459 P1-G ALD-AAAAAAAAAATCTCTAGAGGTGGTTCACCCGTTTGCCTGTCAGACACAAG
rs2162459 P2 Phosphate-TGTATGATAGACATGGATGA-biotin
rs2162459 Target for P1-A TCATCCATGTCTATCATACATTTGTGTCTGACAGGCAAACG
rs2162459 Target for P1-G TCATCCATGTCTATCATACACTTGTGTCTGACAGGCAAACG
rs2162459 Forward AAATTGCAGAGCACAGCC
rs2162459 Reverse TCAAAGTTTGAAGTCAGTGGG
rs3808607 P1-G ALD-AAAAAAAAAACAAAGCAATCAGAGACCTGCAATACTTGATAAGTTGAAGG
rs3808607 P1-T ALD-AAAAAAAAAACAAAGCAATCAGAGACCTGCAATACTTGATAAGTTGAAGT
rs3808607 P2 Phosphate-TCTCTCAAATATATGTTGAC-biotin
rs3808607 Target for P1-G GTCAACATATATTTGAGAGACCTTCAACTTATCAAGTATTG
rs3808607 Target for P1-T GTCAACATATATTTGAGAGAACTTCAACTTATCAAGTATTG
rs3808607 Forward AGTCCACAGGTATCAGAAGTG
rs3808607 Reverse CCCCAGGTCCGAATGTTAAG
rs7833904 P1-A ALD-AAAAAAAAAACAGGAGAAAGCGTAAGTGCCCTGACAAAGAAAAGAGGTAA
rs7833904 P1-T ALD-AAAAAAAAAACAGGAGAAAGCGTAAGTGCCCTGACAAAGAAAAGAGGTAT
rs7833904 P2 Phosphate-AGTTGCCAGAAAACCTGGCA-biotin
rs7833904 Target for P1-A TGCCAGGTTTTCTGGCAACTTTACCTCTTTTCTTTGTCAGG
rs7833904 Target for P1-T TGCCAGGTTTTCTGGCAACTATACCTCTTTTCTTTGTCAGG
rs7833904 Forward AATGTGAGCAAGAAAGCCC
rs7833904 Reverse GAACTCAGTTTATTTTGCCAGG
rs1125226 P1-A ALD-AAAAAAAAAACAACTGGTTCATCAGACTTGCTGCGACCAATTAACCTTGA
rs1125226 P1-C ALD-AAAAAAAAAACAACTGGTTCATCAGACTTGCTGCGACCAATTAACCTTGC
rs1125226 P2 Phosphate-CAGCTCAGGGAGAGAGAGAG-biotinPage 8 of 12
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CYP7A1 gene. In JPT, a weak linkage makes the proximal
part block extended into the 3'-UTR. In CHB and African-
Americans, there is no LD existing in this area.
Conclusion
Here we demonstrate a genetic approach to analyze LD
patterns and haplotype blocks in CYP7A1 gene. Various
degree of LD is found across different regions in different
populations. A set of htSNPs is identified that can be used
in an association study to capture common haplotypes in
different populations. An inexpensive genotyping plat-
form on thin-film biosensor chips is established to geno-
type the htSNPs. This chip technology can be applied in
any laboratory with basic molecular genetic setting. The
defined haplotype block structure in CYP7A1 gene may
lead to a better design for genetic association studies to
correlate genetic variations in CYP7A1 gene to cholesterol
and bile acid metabolism and human diseases, such as
gallstone disease. Because of high polymorphism and
strong LD in the promoter region of CYP7A1, it should be
considered in future studies to evaluate which CYP7A1
promoter haplotypes are more efficient for transcriptional
regulation by its regulatory factors, such as FXR, LXR, RXR,
PXR, SHP, and LRH1.
Methods
Human subject
The DNA samples for the HapMap come from a total of
270 people: 90 individuals from the Yoruba of Ibadan,
Nigeria (YRI), (30 sets of trios, each trio with samples
from two parents and an adult child); 90 individuals (30
sets of trios) from U.S. residents with northern and west-
ern European ancestry collected by the Centre d'Etude du
Polymorphisme Humain (CEU); 45 unrelated individuals
from the Tokyo area in Japan (JPT); and 45 unrelated indi-
viduals from Beijing, China (CHB). Two American popu-
lation samples of Mexican-Americans and African-
Americans were also used in this study. These DNA sam-
ples were collected by other research projects on alcohol-
ism in the Mexican-American population [30] and
pharmacogenomics of CYP enzymes in African-Americans
[32]. Studies on these human subjects were approved by
the Human Subjects Committee of the Kansas University
Medical Center. Ninety DNA samples of healthy individ-
uals were randomly selected from each population.
Analysis of linkage disequilibrium blocks and haplotype 
structure
LD patterns and haplotype structures of CYP7A1 gene in
the HapMap populations were analyzed by using geno-
type data from the HapMap database. In the HapMap
Phase II database, a total of about 5.9 million SNPs
(about 1 SNP every 500 bp across the genome) are typed
in the four HapMap populations [21]. Genotypes of each
selected SNP in the 270 HapMap population samples can
be downloaded from its database [34]. Fourteen SNPs are
genotyped by the HapMap project in a total of 25 kb
region with 10 kb of 5'-upstream flanking, 5 kb of 3'-
downstream flanking, and the CYP7A1 gene sequences.
The SNP density is about 1.8 kb per SNP. The CYP7A1 A-
278C (or A-204C) promoter polymorphism is included
with an ID number of rs3808607. A close promoter poly-
morphism C-554T, which was identified together with A-
278C by Wang et al. [7], is also included as rs3824260.
Chromosomal positions and locations in the CYP7A1
gene regions of the 14 SNPs are listed in Table 1 with pol-
ymorphic allele 1 for common allele and allele 2 for less
rs1125226 Target for P1-A CTCTCTCTCTCCCTGAGCTGTCAAGGTTAATTGGTCGCAGC
rs1125226 Target for P1-C CTCTCTCTCTCCCTGAGCTGGCAAGGTTAATTGGTCGCAGC
rs1125226 Forward TTTCTCTCTCTCCCTCTTTCTC
rs1125226 Reverse CTGGTTCATCAGACTTGCTG
rs1023652 P1-C ALD-AAAAAAAAAAAAAATTCAAGTACCATAATATTCACCCCTTTAAAGAGTAC
rs1023652 P1-G ALD-AAAAAAAAAAAAAATTCAAGTACCATAATATTCACCCCTTTAAAGAGTAG
rs1023652 P2 Phosphate-AATTCAAAATTTCTAGCATA-biotin
rs1023652 Target for P1-C TATGCTAGAAATTTTGAATTGTACTCTTTAAAGGGGTGAAT
rs1023652 Target for P1-G TATGCTAGAAATTTTGAATTCTACTCTTTAAAGGGGTGAAT
rs1023652 Forward TGGAATGCCAGTTACCCCAC
rs1023652 Reverse GGTGATGGTCACACAATCTTTG
1302 delTT P1-TT ALD-AAAAAAAAAATGTATTTTTATTGCAGACTTTTAAATATGATAGGTATCTT
1302 delTT P1-DEL ALD-AAAAAAAAAATTTGTATTTTTATTGCAGACTTTTAAATATGATAGGTATC
1302 delTT P2 Phosphate-GATGAAAACGGGAAGACAAA-biotin
1302 delTT Target for P1-TT TGTCTTCCCGTTTTCATCAAGATACCTATCATATTTAAAA
1302 delTT Target for P1-DEL TGTCTTCCCGTTTTCATCGATACCTATCATATTTAAAA
1302 delTT Forward ACTAGCTTAAAGGCGGTTTTC
1302 delTT Reverse CGATCCAAAGGGCATGTAG
* Shadows indicate SNP nucleotides in P1 probe and target sequences.
Table 4: Oligonucleotide sequences of capture probe P1, detection probe P2, synthetic targets, and PCR primers. (Continued)Page 9 of 12
(page number not for citation purposes)
BMC Genetics 2006, 7:29 http://www.biomedcentral.com/1471-2156/7/29common allele in CEU. Genotypes of each individual
samples for the 14 SNP markers were dumped from the
HapMap database and saved as a HapMap formatted file
that can be opened directly by HaploView 3.12 for defin-
ing LD patterns and haplotype structure [25]. Four Hap-
Map files were separately saved for CEU, CHB, JPT, and
YRI, respectively. By uploading the files into HaploView,
frequencies of allele 2, frequencies of observed hetero-
zygous genotypes, and Hardy-Weinberg p-value for each
marker were summarized for each population (see Table
2). No marker has a HW p-value smaller than the cutoff
value of 0.0010 in the four populations. The LD between
any two markers was defined by HaploView 3.12. A stand-
ard color scheme is used to display LD in Figure 1. A LD
block was created by confidence intervals [25] if 95% of
the informative comparisons are in strong LD using
default algorithms of 95% confidence bounds on D
prime. Haplotypes structure was defined by using an
accelerated EM algorithm, similar to the partition/ligation
method [33]. This creates highly accurate population fre-
quency estimates of the phased haplotypes, based on the
maximum likelihood as determined from the unphased
input. Haplotypes with frequency > 2% in a block in CEU,
YRI, JPT, and CHB are displayed in Figure 2. Alleles with
blue boxes and red boxes represent common alleles and
less common alleles in CEU, defined as Allele 1 and Allele
2, respectively. In the crossing areas, a value of multiallelic
D' is shown to represent the level of recombination
between the two blocks.
Genotyping on thin-film biosensor chip
For each selected SNP, target DNA molecules from each
sample were amplified by PCR. PCR primers were
designed based on the following criteria to make the PCR
reaction uniform: (1) product size should be 120–200 bp
with about 50–100 base flanking sequences around the
SNP site in both directions, and (2) annealing tempera-
ture should be about 60°C for a standard PCR reaction
condition. The best primer sets were selected by DS Gene
Software version 1.5 (accelrys). The primer sequences for
each SNP site are listed in Table 4. The selected primer
sequences were synthesized by Invitrogen (Carlsbad, Cal-
ifornia). Multiple sets of the PCR products were amplified
in a single PCR reaction.
For each SNP, three oligonucleotide probes were synthe-
sized. A pair of allele specific P-1 oligos, differing only in
their 3'-terminal nucleotide sequence, generally has 40
nucleotides complementary to the corresponding target
sequences, and an additional 10-dA residue at their 5'-
Table 5: Allele frequencies of the selected CYP7A1 htSNPs and mutation markers A. in the Mexican-American population.
# SNP ID Variation 
Allele 1/2
Observed genotype frequencies Observed allele 
frequencies
Hardy-Wenberg
Homo 
Allele 1
Hetero Homo 
Allele 2
Allele 1 Allele 2 Expect 
heterozygous
P value
1 rs10504255 A/G 0.71 0.25 0.03 0.84 0.16 0.27 0.79
2 rs8192879 C/T 0.41 0.42 0.18 0.61 0.39 0.47 0.34
3 rs11786580 C/T 0.75 0.25 0 0.87 0.13 0.22 0.45
4 rs8192874 T/C 1.00 0 0 1.00 0
5 rs2162459 A/G 0.59 0.31 0.10 0.75 0.25 0.38 0.13
6 rs3808607 T/G 0.62 0.30 0.09 0.76 0.24 0.37 0.09
7 rs7833904 T/A 0.64 0.30 0.07 0.79 0.21 0.33 0.37
8 rs1125226 A/C 0.62 0.30 0.08 0.78 0.22 0.34 0.18
9 rs1023652 C/G 0.67 0.26 0.07 0.81 0.19 0.32 0.14
10 1302 delTT TT/– 1.00 0 0 1.00 0
B. in the African-American population
1 rs10504255 A/G 0.81 0.18 0.01 0.84 0.10 0.18 1.00
2 rs8192879 C/T 0.56 0.36 0.08 0.61 0.26 0.38 0.82
3 rs11786580 C/T 0.60 0.36 0.04 0.87 0.22 0.34 0.90
4 rs8192874 T/C 1.00 0 0 1.00 0
5 rs2162459 A/G 0.25 0.34 0.41 0.75 0.58 0.49 0.01
6 rs3808607 T/G 0.23 0.36 0.40 0.76 0.58 0.49 0.03
7 rs7833904 T/A 0.20 0.50 0.30 0.79 0.55 0.50 1.00
8 rs1125226 A/C 0.20 0.49 0.31 0.78 0.56 0.49 1.00
9 rs1023652 C/G 0.33 0.38 0.29 0.81 0.49 0.50 0.04
10 1302 delTT TT/-- 1.00 0 0 1.00 0
* Shadows indicate SNP nucleotides in P1 probe and target sequences.Page 10 of 12
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otide is modified with an aldehyde group, allowing cova-
lent attachment to the chip surface [27]. A second
oligonucleotide probe (biotin-P2) with 20 nucleotides
immediately adjacent to the SNP nucleotide carries a
biotin at the 3' end for detection, and a phosphate at its 5'
end for ligation. To test genotyping specificity, a pair of
oligonucleotide targets was also synthesized. The P1, P2
and target sequences for each SNP are listed in Table 4.
The synthesized P1 oligos were dissolved to 100 µM in 0.1
M phosphate buffer, pH 7.8. A P1 working solution of 1
µM in 0.1 M phosphate buffer, pH 7.8, and 10% glycerol
was prepared for each P-1 probe before spotting. Twenty
nano liter of the P1 working solution was spotted on a 7
× 7 mm2 chip in an 8 per row × 6 per column format, by
a BioDot PC controlled dispense arrayer AD3200. A dupli-
cate set of P1 probes were spotted on a chip with a spot-
ting pattern shown in Figure 3A. After the spotted chips
were incubated in a humidity-controlled chamber for at
least 2 hrs, the chips were washed with 0.1% SDS, water,
and air dried. A standard operating procedure for geno-
typing SNPs on the printed biosensor chips was described
previously [27]. An arrayed chip was assembled into a
square well of a 96-well microtiter plate for hybridization.
A ligation reaction was carried out in a microtiter plate
well containing an arrayed chip. A reaction solution (100
µl) contained 100 femtomoles of each relevant PCR
amplicon of the 10 CYP7A1 SNPs, 10 nM P-2 probe (one
for each SNP) and 5 units of mutant Ampligase in a buffer
of 20 mM Tris-HCl, pH 8.3, 25 mM KCl, 10 mM MgCl2,
0.5 mM NAD, 0.01% Triton X-100, and 5 mg/ml alkaline
treated casein. The ligation reaction was incubated for 20
min at 60°C. 96 chips in a 96-well plate were processed
simultaneously. After a stringent wash (3 times in 0.01 M
NaOH at room temperature and 3 times in 0.1 × SSC), the
chips were incubated with an antibiotin-horse radish per-
oxidase (HRP) conjugate (1 µg/ml in hybridization
buffer) for 10 min, and the chips were rinsed with 0.1 ×
SSC. 100 µl of a precipitate-generating HRP substrate TMB
(BioFx) was added to each chip and incubated for 5 min,
rinsed in ddH20, and air-dried.
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